CIK 0001034842
- Accelerated filer
RIGEL PHARMACEUTICALS INC
Sign in to watch- Ticker
- RIGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943248524
- Phone
- +1 650-624-1100
- Business address
- 611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- RIGEL PHARMACEUTICALS INC
- 4 Open-market sale EVP & Chief Financial Officer sold 3,770 shares at an average $21.38 ($80,615)
- 4 Open-market sale EVP, Chief Commercial Officer sold 3,921 shares at an average $21.38 ($83,836)
- 4 Open-market sale CEO, President sold 9,352 shares at an average $21.39 ($200,075)
- 4 Open-market sale EVP, GC, CCO & Corp Sec sold 2,787 shares at an average $21.40 ($59,653)
- 4 Grant or award EVP, Chief Medical Officer acquired 19,717 shares (grant or award)
- 4 Grant or award CEO, President acquired 42,300 shares (grant or award)
- 4 Grant or award EVP & Chief Financial Officer acquired 19,717 shares (grant or award)
- 4 Grant or award EVP, Chief Commercial Officer acquired 19,717 shares (grant or award)
- 4 Grant or award EVP, GC, CCO & Corp Sec acquired 19,717 shares (grant or award)
- 4 Shares withheld for taxes CEO, President gave up 88,156 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 25,000 shares (grant or award)
- 4 Grant or award Director acquired 25,000 shares (grant or award)
- 4 Grant or award Director acquired 25,000 shares (grant or award)
- 4 Grant or award Director acquired 25,000 shares (grant or award)
- 4 Grant or award Director acquired 25,000 shares (grant or award)
Page 4 of 34 · 664 filings